Huerta, Ana; López-Sánchez, Paula; Martínez, Eduardo; Quintana, Luis-F; Martin-Gómez, Adoracion; Lopes, Vanessa; Rabasco, Cristina; Rodríguez, Jorge-Alberto; Rodríguez, Celia; Temprado, Alba; López-Mendoza, Manuel; Borrego, Francisco-José; Afonso, Sara; Rodríguez, Antolina; Fernández, Loreto; Gago, María; Prados, María-del-Carmen; Gracia, Olga; Sierra, Milagros; Sánchez-Agesta, Marina; Carbayo, Javier; Hadad-Arrascue, Fernando; Romera, Ana; Cox, Roger; Mora, José-María; Rivas, Begona; Fernández-Solis, Juan; Gómez-Preciado, Francisco; Mora, María-Teresa; Marquez, Eva; Espino, Mar; Larramendi, Carmen; López-Corbeto, Mireia; Devolder-Nicolau, Adriana; Puente-García, Adriana; Shabaka, Amir; González, Sara; Martin, Carmen; Mon, Carmen; Tato, Ana; Villa, Daniel; Galindo, María; Martin-Testillano, Lucía; Portoles, José; Morales, Enrique
(FRONTIERS MEDIA SA, 2026-08-25)
OBJECTIVES: Belimumab has emerged as a therapeutic option for lupus nephritis (LN); however, real-world evidence on its effectiveness remains limited. This study aimed to evaluate the effectiveness and safety of belimumab ...